A panel of journalists joins Diane for analysis of the week's top international news stories.
Stem cell research promises to provide new therapies, preventive measures and even cures for some major human diseases and disorders. But some policymakers, like many Americans, have deep misgivings about the use of human embryonic tissue for this purpose. A panel talks about the therapeutic potential of stem cells, the ethical issues raised by the work, and federal funding for the research.
- Dr. Robert Goldstein chief scientific officer for the Juvenile Diabetes Foundation International
- Dr. David Prentice of Do No Harm: Coalition of Americans for Research Ethics
- Rick Weiss science reporter for "The Washington Post"
Most Recent Shows
A panel of journalists joins Diane for analysis of the week's top national news stories.
The National Endowment for the Humanities turns 50 next year. William “Bro” Adams, the new chairman of the National Endowment for the Humanities, wants to make sure that the study of history, philosophy, and literature remains accessible to everyone. A conversation about his new "Common Good" initiative.
The Cystic Fibrosis Foundation is earning more than $3 billion from its investment in a new drug. Other charitable organizations are hoping to follow a similar path. New opportunities and new questions for nonprofits.